Uncategorized
ADA: Lilly’s weight loss mastery shows benefits in menopause, sleep apnea, more
Eli Lilly sauntered into the American Diabetes Association meeting with a commanding lead in the metabolic space and put down more evidence for its pipeline, including new pill Foundayo and next-gen asset retatrutide, in new indications.